CollPlant Biotechnologies Ltd.
CLGN
$2.71
$0.083.04%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -28.11% | -45.15% | -97.55% | -77.37% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -28.11% | -45.15% | -97.55% | -77.37% | |
| Cost of Revenue | -65.30% | -64.81% | -12.85% | 67.69% | |
| Gross Profit | 97.56% | 77.22% | -103.00% | -513.89% | |
| SG&A Expenses | -18.57% | -10.67% | 7.89% | -3.21% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -27.88% | -22.90% | 3.28% | 12.02% | |
| Operating Income | 27.87% | 21.59% | -177.61% | -23.02% | |
| Income Before Tax | 20.50% | 17.30% | -173.06% | -12.92% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 20.50% | 17.30% | -173.06% | -12.92% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 20.50% | 17.30% | -173.06% | -12.92% | |
| EBIT | 27.87% | 21.59% | -177.61% | -23.02% | |
| EBITDA | 28.85% | 21.99% | -169.75% | -25.01% | |
| EPS Basic | 23.07% | 17.29% | -172.51% | -11.13% | |
| Normalized Basic EPS | 23.07% | 17.31% | -172.51% | -- | |
| EPS Diluted | 23.07% | 17.29% | -175.00% | -11.00% | |
| Normalized Diluted EPS | 23.07% | 17.31% | -175.11% | -- | |
| Average Basic Shares Outstanding | 3.37% | 0.01% | 0.75% | 1.62% | |
| Average Diluted Shares Outstanding | 3.37% | 0.01% | -2.74% | 1.62% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |